Can Valsartan Make You Tired? Explaining the Side Effect

Fatigue is one of the most commonly reported complaints among people taking valsartan, yet clinical trial data consistently show that tiredness occurs at nearly the same rate in people taking a placebo. In controlled studies of valsartan for high blood pressure, the incidence of fatigue was not significantly different between the drug and placebo groups.¹ That does not mean the tiredness you feel is imaginary. It means the explanation is more interesting than a simple drug-causes-side-effect story, and understanding it can help you figure out what to do about it.

What the Trial Data Actually Show

When researchers run placebo-controlled studies, they compare adverse events between people getting the real drug and people getting a sugar pill. For valsartan, the pattern is strikingly consistent: fatigue shows up as one of the top three reported events, alongside headache and dizziness, but it does so in both groups at similar rates.¹ In a trial of patients with heart failure, fatigue was reported by about 10% of those on valsartan and 11% of those on placebo.² Dizziness followed a similar pattern in that trial, at roughly 14% versus 17%.

This does not mean fatigue is a myth. What it tells us is that valsartan, as a direct pharmacological cause, is unlikely to be the sole culprit. The tiredness people feel is real, but the source is usually more complicated than “the pill made me sleepy.” Several interacting factors explain why you feel more tired after starting valsartan, even though the drug itself may not be the primary driver.

Blood Pressure Drops and the Adjustment Period

The most common reason people feel wiped out after starting valsartan is the blood pressure reduction itself. If your body has been running at a high pressure for months or years, it has adapted to that state. Your brain, muscles, and organs have been receiving blood flow calibrated to that elevated pressure. When valsartan brings your numbers down, everything that was adapted to higher pressure now receives less forceful perfusion, and the result feels like exhaustion, lightheadedness, or a general sense of low energy.

This effect tends to be most noticeable in the first few weeks. In a study of hypertensive patients with sleep apnea, valsartan lowered 24-hour mean blood pressure by about 9 mmHg, with significant reductions during both daytime and nighttime hours.³ A drop of that size can be enough to make you feel sluggish, especially if you were previously unmedicated. The nighttime blood pressure reduction is relevant too: lower nighttime pressure can leave you feeling unrested in the morning, even though better-controlled nighttime pressure is generally healthier for your heart and kidneys over the long run.

For most people, the fatigue from this adjustment fades within two to six weeks as the body recalibrates. If it lingers well beyond that window, something else is usually going on.

How the Renin-Angiotensin System Connects to Energy Levels

Valsartan works by blocking angiotensin II receptors, which are part of the renin-angiotensin system (RAS). Angiotensin II is a hormone that constricts blood vessels and raises blood pressure, so blocking it lets vessels relax and pressure fall. But the RAS does not operate in isolation. Research has found that the brain’s own renin-angiotensin system participates in regulating neurotransmitter release and influences the sympathetic nervous system, the network responsible for your “fight or flight” response.⁴

When you block angiotensin II receptors, sympathetic nerve activity can shift. In people with hypertension, the sympathetic nervous system is often running hot, and dialing it back is part of why blood pressure medications work. But the sympathetic system also governs alertness, motivation, and physical readiness. A reduction in sympathetic tone can register subjectively as tiredness even when it is doing exactly what your cardiovascular system needs. This is the pharmacological equivalent of your body going from a state of constant low-grade alarm to something calmer, and that calmer state can feel like fatigue until you get used to it.

Potassium Levels and Hidden Fatigue

One underappreciated contributor to fatigue on valsartan is potassium. All drugs that block the renin-angiotensin system, including valsartan, reduce the body’s excretion of potassium. In most people this effect is clinically insignificant, but in certain populations the potassium level can climb high enough to cause symptoms. In a study of over 3,000 hospitalized patients taking either an ACE inhibitor or an ARB like valsartan, hyperkalemia occurred in a small but measurable fraction, and the risk was substantially higher in patients with chronic kidney disease.⁵

Elevated potassium does not always announce itself with dramatic symptoms. Mild hyperkalemia can cause muscle weakness, a vague feeling of heaviness, and fatigue that is easily mistaken for a side effect of the blood pressure pill rather than a metabolic disturbance. If you have kidney disease, diabetes, or take potassium-sparing diuretics alongside valsartan, your doctor should be checking your potassium levels periodically. Persistent unexplained fatigue in that context is worth a blood draw, not just reassurance.

Genetic Variation in How Your Body Processes Valsartan

Not everyone metabolizes valsartan at the same rate, and the difference can be dramatic. Valsartan is processed in part by a liver enzyme called CYP2C9, and this enzyme’s efficiency varies widely across the population based on genetics. A study examining 38 different CYP2C9 variants found that 12 of them caused greater than 90% decreases in the enzyme’s ability to clear valsartan from the body, while a few other variants slightly increased clearance.⁶

If you carry one of the slower-metabolizing variants, a standard dose of valsartan may produce higher and more sustained drug levels in your blood than your doctor expects. That effectively means you are experiencing a stronger blood pressure drop, more angiotensin II blockade, and more of the physiological shifts described earlier. All of these translate to more fatigue. This is one reason why the same 80 mg or 160 mg dose can make one person feel fine and leave another feeling drained. Pharmacogenomic testing is not routine for valsartan prescribing, but it is becoming more accessible, and if you are unusually sensitive to the drug’s effects, slow metabolism is worth considering.

The Erythropoietin Question in Kidney Disease

People with chronic kidney disease face an additional wrinkle. Valsartan has been shown to significantly reduce levels of erythropoietin (EPO), the hormone that signals your bone marrow to make red blood cells. In one study of patients with stage III-IV kidney disease, EPO levels dropped significantly at three, six, and ninety days after starting valsartan.⁷ Interestingly, hemoglobin levels did not fall significantly over the same period, suggesting the body compensated through other pathways.

This finding matters because EPO does not only affect red blood cell production. It has broader effects on tissue oxygenation and energy metabolism. A significant EPO drop without a corresponding hemoglobin drop means the safety margin is thinner: any additional stressor, such as mild bleeding, poor nutrition, or inflammation, could tip the balance into anemia. For kidney disease patients on valsartan who feel persistently tired, monitoring both EPO and hemoglobin gives a more complete picture than hemoglobin alone. The research also noted that ARBs like valsartan may be preferable to ACE inhibitors in kidney disease patients precisely because they are less likely to cause frank anemia despite the EPO reduction.

Does It Matter When You Take It?

A question that comes up frequently is whether taking valsartan in the morning versus the evening changes its side-effect profile, particularly fatigue. A clinical trial specifically tested this by randomizing patients to morning or evening doses and comparing blood pressure effects over 26 weeks. The results were clear: the 24-hour blood pressure reduction was comparable regardless of timing. Morning dosing lowered systolic blood pressure by about 13 mmHg at 26 weeks, and evening dosing achieved about 12 mmHg, a difference that was not meaningful. Evening dosing did not improve nighttime blood pressure or early morning blood pressure compared to morning dosing, even in patients whose blood pressure did not normally dip at night.⁸

What this means practically is that switching your dose from morning to evening, or vice versa, is unlikely to resolve fatigue if the drug itself is the cause. Some people feel better taking it at bedtime because they sleep through the initial blood pressure dip, but the trial data do not support a physiological advantage to either schedule. If morning dosing makes you drowsy at work, it is reasonable to try bedtime dosing as a practical accommodation, but do not expect the overall effect on your energy levels to change much.

How Valsartan Compares to Other Blood Pressure Medications

ARBs like valsartan were specifically developed to produce fewer side effects than older classes of blood pressure medications. Clinical trials have confirmed that ARBs are about as effective as calcium-channel blockers, beta-blockers, and ACE inhibitors at lowering blood pressure, while generally causing fewer adverse effects.⁹ This is an important point of context, because beta-blockers, for example, are notorious for causing fatigue through a fundamentally different mechanism: they slow the heart rate and blunt the body’s adrenaline response, which directly dampens physical energy. ACE inhibitors share valsartan’s mechanism of blocking the renin-angiotensin system but are associated with a higher frequency of cough, which itself can cause sleep disruption and daytime tiredness.

If you are experiencing fatigue on valsartan and are wondering whether switching medications would help, the honest answer is that it depends on the cause. If your fatigue is driven by blood pressure reduction itself, any effective antihypertensive will produce a similar adjustment period. If it is driven by a specific pharmacological property like sympathetic tone changes or potassium handling, switching drug classes could make a noticeable difference. A move to a calcium-channel blocker like amlodipine, for instance, lowers blood pressure through a completely different pathway and tends to have a different side-effect signature, with ankle swelling being more common than fatigue. Switching within the ARB class (from valsartan to losartan, for example) is less likely to help, since the mechanism of action is the same.

When Fatigue on Valsartan Warrants a Doctor Visit

Some degree of low energy in the first weeks of treatment is expected and usually resolves. But certain patterns of fatigue are worth bringing up with your prescriber rather than waiting out.

• Persistent fatigue: If you have been on valsartan for more than six to eight weeks and the tiredness has not improved, something beyond simple adjustment is likely at play. Potassium, kidney function, thyroid levels, and hemoglobin are all worth checking.
• Worsening fatigue: Tiredness that gets worse over time rather than better is a red flag. This pattern can indicate progressive hyperkalemia, worsening kidney function, or an interaction with another medication added since you started valsartan.
• Fatigue with dizziness or irregular heartbeat: Patients should report any severe or persistent symptoms including dizziness, swelling, or irregular heartbeat, and particular caution applies when valsartan is combined with other blood-pressure-lowering drugs, which can compound the pressure drop.¹⁰
• Fatigue with muscle cramps or weakness: This combination can signal hyperkalemia and warrants a same-week lab check, especially if you have diabetes or kidney disease.

The point is not to be alarmed by tiredness on valsartan, which is common and usually benign, but to distinguish the normal adjustment from signals that deserve investigation. Your doctor cannot troubleshoot fatigue without lab data, so a conversation that leads to blood work is more productive than one that ends with “give it time.”

Other Conditions That Masquerade as a Drug Side Effect

One reason fatigue on valsartan is tricky to pin down is that the people who take valsartan tend to have conditions that cause fatigue independently. Hypertension itself, when poorly controlled, disrupts sleep architecture and increases the risk of obstructive sleep apnea. Heart failure causes exercise intolerance and tiredness through reduced cardiac output. Diabetes, which frequently co-occurs with hypertension, produces fatigue through blood sugar fluctuations and neuropathy. Kidney disease brings its own brand of deep tiredness through fluid retention, electrolyte disturbances, and anemia.

When someone starts valsartan and feels tired, the instinct is to blame the new variable. But the timing can be coincidental, or the fatigue may have been building from the underlying condition and only became noticeable once the acute worry about blood pressure was addressed. Sleep apnea is a particularly common confounder. In a study comparing valsartan to CPAP therapy in hypertensive patients with sleep apnea, valsartan lowered blood pressure far more effectively than CPAP, but CPAP directly addressed the apnea-related fatigue.³ If you have untreated sleep apnea and are blaming valsartan for your tiredness, you may be addressing the wrong problem entirely. A sleep study can clarify whether the fatigue has roots that no blood pressure pill can fix.